Luveltamab is a humanized anti-FOLR1 monoclonal antibody, primarily utilized as the targeting component of the ADC Luveltamab tazevibulin. This research tool is applied in leukemia studies, supporting both in vitro cell-based assays and in vivo preclinical research to investigate targeted therapeutic strategies.
Concentration:
6.25 mg/mL
Molecular Weight:
146.09 kDa
Purity:
97.70% (May vary between batches)
Target:
Antifolate
* VAT and and shipping costs not included. Errors and price changes excepted
